In June 2017, the Government of India launched the National Biopharma Mission named i3 to accelerate critical biopharmaceutical development in the country. In this context, what does the abbreviation i3 stand for?

Introduction / Context:
The National Biopharma Mission is a major initiative of the Government of India aimed at strengthening the domestic biopharmaceutical industry. Launched in June 2017, it focuses on improving infrastructure, supporting innovation, and speeding up development of vaccines, biologics, and medical products. The mission is popularly branded as i3, and general knowledge questions often test whether candidates know the correct expansion of this abbreviation.

Given Data / Assumptions:
- The mission is called the National Biopharma Mission.- It was launched in June 2017 to accelerate biopharma development.- The brand name used is i3.- We must identify the correct phrase represented by i3 from the options.

Concept / Approach:
The word biopharma refers to biologically based pharmaceutical products, and India wants to move from being mainly a generic manufacturer to a global innovation hub. To communicate this vision, the mission name uses i3 to highlight a key action phrase. Official documents and press releases expand i3 as Innovate in India, focusing on building innovation capacity in the domestic ecosystem rather than simply importing technologies or only investing money.

Step-by-Step Solution:
Step 1: Recall that the mission is designed to promote research, innovation, and product development in the Indian biopharma sector.Step 2: Look at the options and see which phrase best matches that aim. Innovate in India directly connects innovation with India as a location.Step 3: Invest in India is a common slogan for attracting capital, but the mission is more about technology and product development than only investment.Step 4: Introduce in India does not capture the idea of locally driven innovation and is not used in official branding.Step 5: Since government releases clearly expand i3 as Innovate in India, that must be selected as the correct answer.

Verification / Alternative Check:
If you quickly search for official descriptions of the National Biopharma Mission, they explicitly mention i3 as standing for Innovate in India. This matches the missions objective of building an innovation ecosystem across academia, industry, and regulators rather than simply channeling funds or importing finished technologies.

Why Other Options Are Wrong:
Invest in India: Sounds attractive but is more appropriate for general investment campaigns like Make in India, not specifically this biopharma mission.Introduce in India: This phrase would suggest bringing in foreign products, which is not the core goal of the mission.No option is correct.: This is incorrect because one of the options exactly matches the official expansion.

Common Pitfalls:
A common mistake is to assume that any positive sounding phrase beginning with I is acceptable, especially Invest in India, which is familiar from other campaigns. However, general knowledge questions often test these subtle differences, so candidates must link i3 specifically with innovation in the biopharmaceutical context. Careful reading of government schemes and authentic sources is essential to avoid confusion among similar slogans.

Final Answer:
Innovate in India is the correct expansion of i3 in the National Biopharma Mission.